Skip to main content Accessibility help
×
Home
  • Cited by 3
  • Print publication year: 2015
  • Online publication date: September 2015

Chapter 11 - Managing patients with psychiatric conditions treated with deep brain stimulation

Related content

Powered by UNSILO
1.El-Hai, J. The Lobotomist: A Maverick Medical Genius and His Tragic Quest to Rid the World of Mental Illness. Hoboken, NJ: Wiley; 2007.
2.Park, LT, Dougherty, DD, Rauch, SL. Neurosurgical treatments for psychiatric indications. In: Jeste, DV, Friedman, JH, editors. Psychiatry for Neurologists. Current Clinical Neurology. Totowa, NJ: Humana Press; 2006: pp. 339–61.
3.Feldman, RP, Goodrich, JT. Psychosurgery: a historical overview. Neurosurgery 2001;48(3):647–57.
4.Knight, G. Stereotactic tractotomy in the surgical treatment of mental illness. J Neurol Neurosurg Psychiatry 1965;28(4):304–10.
5.Herner, T. Treatment of Mental Disorders With Frontal Stereotaxic Thermo-Lesions: A Follow-Up Study of 116 Cases. Copenhagen: Munksgaard; 1961.
6.Greenberg, BD, Rauch, SL, Haber, SN. Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology 2010;35(1):317–36.
7.Bingley, T, Leksell, L, Meyerson, BA, Rylander, G. Long-term results of stereotactic capsulotomy in chronic obsessive compulsive neurosis. In: Sweet, WH, Obrador, S, Martin-Rodriguez, JG, editors. Neurosurgical Treatment in Psychiatry, Pain, and Epilepsy. Baltimore, MD: University Park Press; 1977; pp. 287–89.
8.Ballantine, HT Jr., Bouckoms, AJ, Thomas, EK, Giriunas, IE. Treatment of psychiatric illness by stereotactic cingulotomy. Biol Psychiatry 1987;22(7):807–19.
9.Sheth, SA, Neal, J, Tangherlini, F, et al. Limbic system surgery for treatment – refractory obsessive–compulsive disorder: a prospective long-term follow-up of 64 patients. J Neurosurg 2013;118(3):491–97.
10.Kelly, D, Richardson, A, Mitchell-Heggs, N. Stereotactic limbic leucotomy: neurophysiological aspects and operative technique. Br J Psychiatry 1973;123(573):133–40.
11.Montoya, A, Weiss, AP, Price, BH, et al. Magnetic resonance imaging-guided stereotactic limbic leukotomy for treatment of intractable psychiatric disease. Neurosurgery 2002;50(5):1043–52.
12.Milad, MR, Rauch, SL. Obsessive–compulsive disorder: beyond segregated cortico-striatal pathways. Trends Cogn Sci 2012;16(1):4351.
13.Nuttin, B, Cosyns, P, Demeulemeester, H, Gybels, J, Meyerson, B. Electrical stimulation in anterior limbs of internal capsules in patients with obsessive–compulsive disorder. The Lancet 1999;354(9189); 1526.
14.Gabriëls, L, Cosyns, P, Nuttin, B, Demeulemeester, H, Gybels, J. Deep brain stimulation for treatment-refractory obsessive–compulsive disorder: psychopathological and neuropsychological outcome in three cases. Acta Psychiat Scand 2003;107(4):275–82.
15.Abelson, JL, Curtis, GC, Sagher, O, et al. Deep brain stimulation for refractory obsessive–compulsive disorder. Biol Psychiatry 2005;57(5):510–16.
16.Greenberg, BD, Gabriels, LA, Malone, DA, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive–compulsive disorder: worldwide experience. Molec Psychiatry 2010;15(1):6479.
17.Corse, AK, Chou, T, Arulpragasam, AR, et al. Deep brain stimulation for obsessive–compulsive disorder. Psychiatric Ann 2013;43(8):351–57.
18.Dougherty, DD. RECLAIM: A Randomized Sham-controlled Trial of DBS of the Ventral Capsule/Ventral Striatum (VC/VS) for Treatment-resistant Depression. Philadelphia, PA: Society of Biological Psychiatry; 2012.
19.Malone, DA, Dougherty, DD, Rezai, AR, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 2009;65(4):267–75.
20.Bewernick, BH, Hurlemann, R, Matusch, A, et al. Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 2010;67(2):110–16.
21.Bewernick, BH, Kayser, S, Sturm, V, Schlaepfer, TE. Long-term effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology 2012;37(9):1975–85.
22.Mayberg, HS, Lozano, AM, Voon, V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005;45(5):651–60.
23.Kennedy, SH, Giacobbe, P, Rizvi, SJ, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry 2011;168(5):502–10.
24.Van Laere, K, Nuttin, B, Gabriels, L, et al. Metabolic imaging of anterior capsular stimulation in refractory obsessive–compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. J Nucl Med 2006;47(5):740–47.
25.Goodman, WK, Price, LH, Rasmussen, SA, et al. The Yale–Brown Obsessive Compulsive Scale: I. development, use, and reliability. Arch Gen Psychiatry 1989;46(11):1006–11.
26.Williams, NR, Short, EB, Sahlem, G, et al., editors. Deep brain stimulation to the reward circuitry exerts antidepressant effects on treatment-resistant depression in a patient with Parkinson's disease. Society of Biological Psychiatry Annual Meeting, 2014; New York, NY.
27.Garnaat, SL, Greenberg, BD, Sibrava, NJ, et al. Who qualifies for deep brain stimulation for OCD? Data from a naturalistic clinical sample. J Neuropsychiatry Clin Neurosci 2014;26(1):8186.
28.Haq, IU, Foote, KD, Goodman, WG, et al. Smile and laughter induction and intraoperative predictors of response to deep brain stimulation for obsessive-compulsive disorder. NeuroImage 2011;54(Supplement 1):S247–55.
29.Haber, SN, Heilbronner, SR. Translational research in OCD: circuitry and mechanisms. Neuropsychopharmacology 2013;38(1):252–53.
30.Holtzheimer, PE, Kelley, ME, Gross, RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry 2012;69(2):150–58.
31.Montgomery, SA, Asberg, M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134(4):382–89.
32.Spitzer, RL, Kroenke, K, Williams, JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282(18):1737–44.
33.Rush, AJ, Trivedi, MH, Ibrahim, HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54(5):573–83.
34.Greenberg, BD, Malone, DA, Friehs, GM, et al. Three-year outcomes in deep brain stimulation for highly resistant obsessive–compulsive disorder. Neuropsychopharmacology 2006;31(11):2384–93.
35.Okun, MS, Mann, G, Foote, KD, et al. Deep brain stimulation in the internal capsule and nucleus accumbens region: responses observed during active and sham programming. J Neurol Neurosurg Psychiatry 2007;78(3):310–14.
36.Rodriguez-Romaguera, J, Do Monte, FHM, Quirk, GJ. Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear. Proc Natl Acad Sci USA 2012;109(22):8764–69.
37.Do-Monte, FH, Rodriguez-Romaguera, J, Rosas-Vidal, LE, Quirk, GJ. Deep brain stimulation of the ventral striatum increases BDNF in the fear extinction circuit. Front Behav Neurosci 2013;7:102.
38.Goni, J, van den Heuvel, MP, Avena-Koenigsberger, A, et al. Resting-brain functional connectivity predicted by analytic measures of network communication. Proc Natl Acad Sci USA 2014;111(2):833–38.
39.Smith, SM, Vidaurre, D, Beckmann, CF, et al. Functional connectomics from resting-state fMRI. Trends Cogn Sci 2013;17(12):666–82.
40.McCracken, CB, Grace, AA. High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo. J Neurosci 2007;27(46):12601–10.
41.Riva-Posse, P, Sueng Choi, K, Holtzheimer, PE, et al. Defining critical white matter pathways mediating successful subcallosal cingulate deep brain stimulation for treatment-resistant depression. Biol Psychiatry 2014;76:963–69.
42.Rosin, B, Slovik, M, Mitelman, R, et al. Closed-loop deep brain stimulation is superior in ameliorating parkinsonism. Neuron 2011;72(2):370–84.
43.Ahmari, SE, Spellman, T, Douglass, NL, et al. Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science 2013;340(6137):1234–39.
44.Burguière, E, Monteiro, P, Feng, G, Graybiel, AM. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science 2013;340(6137):1243–46.
45.Widge, AS, Moritz, CT, editors. Proof of concept of a patient-controllable brain stimulator (closed-loop limbic prosthesis) in a rodent model. 2013 Society for Biological Psychiatry Meeting, May 18, 2013. San Francisco, CA.
46.Milad, MR, Rauch, SL. The role of the orbitofrontal cortex in anxiety disorders. Ann NY Acad Sci 2007;1121(1):546–61.
47.Mayberg, HS. Targeted electrode-based modulation of neural circuits for depression. J Clin Invest 2009 Apr;119(4):717–25.